Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| IRBNet ID 1867369-3 | Other Identifier | VA Sierra Nevada Health Care System |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| VA Sierra Nevada Health Care System | FED |
Not provided
Not provided
Not provided
Thiamine micronutrient deficiency (TD) can cause a variety of non-specific symptoms and leads to several thiamine deficiency disorders such as heart failure, polyneuropathy, Wernicke's Encephalopathy and generalized weakness and debility. Symptoms are often vague and non-specific such as fatigue, leg swelling, imbalance, confusion, mood disorders, gastrointestinal upset, and weakness. Hospitalized Veterans may be particularly susceptible to TD due to food insecurity and chronic illnesses which cause inflammation and increased metabolic demands. This study aims to determine the prevalence of TD in hospitalized Veterans which has never been done before. The investigators also seek to identify risk factors causing TD including acute and chronic forms of inflammation, food insecurity, and dietary habits. Lastly, the investigators hope to clarify the abnormally low levels of blood thiamine that correlate with symptoms of TD that improve with replenishment.
Background: Thiamine deficiency (TD) causes a variety of thiamine deficiency disorders (TDDs) such as neuropsychiatric disturbances, polyneuropathy, ataxia, weakness and falling, and non-ischemic heart failure. Left untreated, TD can be associated with poor quality of life, loss of independence, and inability to complete activities of daily living. The prevalence of TD in non-alcohol using hospitalized Veterans is not known but is probably much higher than the general population. Loss of functional ability leads to increased need for rehabilitation.
The objective of this proposal is to measure the prevalence of TDDs in Veterans who do not use excess alcohol who are ill enough to require hospitalization, determine if inflammation increases the risk of developing TD, and determine the optimal cutoff points for two biomarkers of TD to diagnose of TDDs. The central hypothesis is that TD prevalence is as high as 25% in hospitalized non-alcoholic Veterans, far greater than the historically reported prevalence of 3% or less, and that TDD's occur in the "low normal" range of current cutoff values for available thiamine bioassays. A secondary hypothesis is that inflammatory conditions, which are known to cause cachexia and malnutrition, put hospitalized Veterans at increased risk as they often present with acute inflammatory conditions. The rationale underlying this proposal is that hospital practitioners currently underdiagnose and undertreat TDDs which leads to continued morbidity and loss of function. If the hypothesis is correct that the prevalence is as high as 25%, this knowledge will increase awareness of the problem and lead practitioners to diagnose and treat them more often. In addition, clarifying the "abnormally low" biomarker cutoff levels by measuring them in Veterans with TDDs is very important as the current "normal" ranges were determined in healthy volunteers. The central hypothesis will be tested by pursuing three specific aims: 1) determine the prevalence of TD, as defined by whole blood and plasma thiamine levels together with symptom responsive disease in consecutively hospitalized medicine patients who do not use excessive alcohol; 2) define TDDs as cases with low or "low normal" thiamine levels and symptoms that improve with thiamine replenishment; 3) determine if acute and chronic inflammatory conditions with elevated biomarkers of inflammation increase the risk of developing TDD. The investigators expect to find the prevalence of TD is closer to 25% and that the low end of "normal" biomarker levels as published by reference laboratories is too low, missing a percentage of TDDs.
Research design: To accomplish these aims, the investigators will utilize a prospective cohort study design to determine the prevalence of TD in consecutively hospitalized non-alcoholic medicine patients, as defined by low or "low normal" thiamine biomarker levels and thiamine responsive symptoms. Nested within this the investigators will conduct an open label treatment study with those exhibiting symptoms and define TDDs as cases with low or "low normal" thiamine levels and symptoms of TD that improve with thiamine administration. Lastly, utilizing a nested case control study design with cases being those with a TDD and controls being asymptomatic Veterans with normal biomarkers, determine if acute and chronic inflammatory conditions with elevated biomarkers of inflammation increase the risk of developing TDDs.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hospitalized non-alcoholic Veterans | Any Veteran with full admission to the VA Sierra Nevada Healthcare System Hospital. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Thiamine repletion | Dietary Supplement | If a participant is determined by clinical characteristics or biomarker results to be thiamine deficient, thiamine supplementation was provided. |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Participants With Thiamine Deficiency (Low Plasma Thiamine) Out of Total Number of Enrolled Veterans With Plasma Thiamine Results | The percentage of enrolled non-alcoholic veterans who have thiamine deficiency (defined as low plasma thiamine levels) out of the total number of enrolled Veterans with plasma thiamine results. | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Association of Thiamine Deficiency and Inflammation | Determine if there is an association between thiamine deficiency defined by low plasma thiamine levels, and elevated highly sensitive C-reactive protein indicating inflammation. | Baseline |
| Cut-point Analysis of Thiamine Biomarkers |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Veterans who are admitted to the medicine service at the VA Sierra Nevada Healthcare System hospital in Reno, NV who do not use alcohol to excess. The Veterans will need to live within 75 miles of the medical center to facilitate return for follow up appointments.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elisabeth A Mates, MD PhD | VA Sierra Nevada Health Care System, Reno, NV | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA Sierra Nevada Health Care System, Reno, NV | Reno | Nevada | 89502-0993 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33916273 | Background | Mates E, Alluri D, Artis T, Riddle MS. A Retrospective Case Series of Thiamine Deficiency in Non-Alcoholic Hospitalized Veterans: An Important Cause of Delirium and Falling? J Clin Med. 2021 Apr 1;10(7):1449. doi: 10.3390/jcm10071449. | |
| 33576090 | Background | Gomes F, Bergeron G, Bourassa MW, Fischer PR. Thiamine deficiency unrelated to alcohol consumption in high-income countries: a literature review. Ann N Y Acad Sci. 2021 Aug;1498(1):46-56. doi: 10.1111/nyas.14569. Epub 2021 Feb 11. |
Not provided
Not provided
Deidentified data set will be shared upon request made to Dr. Elisabeth Mates
Not provided
Not provided
Not provided
Not provided
1713 participants were screened. Of those, 336 were being discharged too soon for study procedures, 322 lived too far away, 211 took thiamine, 149 had alcohol use disorder, 134 were excluded for reasons due to study logistics (e.g. lack of provider to complete exams, patient too busy, etc.), and 99 cognitively could not consent. Of the remaining, 256 did not want to participate and 206 were enrolled.
All admissions to the hospital were screened and Veterans were excluded if they reported excess alcohol intake; taking thiamine; lived more than 70 miles from the hospital. Those who passed screening were approached for consent. If they were unable to comprehend and "read back" basic elements of the informed consent (as determined by the U-ARE protocol), they were not included due to prohibitive state laws. The first patient was enrolled on July 19, 2022. The last Veteran was enrolled 8/27/2024.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Veterans Without Alcohol Use Disorder Admitted to the Hospital | Veterans with full admission to the hospital who did not have alcohol use disorder, lived within 70 miles of the hospital, were able to read back key portions of the consent, and who were not taking thiamine supplements. |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation for Thiamine Deficiency |
|
| |||||||||||||||||||||||||||||||||
| Suspected Thiamine Deficiency |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Hospitalized Non-alcoholic Veterans | Veterans with full admission to the VA Sierra Nevada Healthcare System Hospital who do not have alcohol use disorder (AUD). |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Percentage of Participants With Thiamine Deficiency (Low Plasma Thiamine) Out of Total Number of Enrolled Veterans With Plasma Thiamine Results | The percentage of enrolled non-alcoholic veterans who have thiamine deficiency (defined as low plasma thiamine levels) out of the total number of enrolled Veterans with plasma thiamine results. | Enrollees with plasma thiamine levels | Posted | Count of Participants | Participants | Baseline |
|
|
two months
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Hospitalized Non-alcoholic Veterans | Veterans with full admission to the hospital who did not have alcohol use disorder, lived within 70 miles of the hospital, were able to read back key portions of the consent, and who were not taking thiamine supplements. |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Diarrhea | Gastrointestinal disorders | Non-systematic Assessment |
Multiple prolonged work stoppages due to unforeseen events led to lower than expected enrollment. Poor compliance with follow up visits after initial evaluation in the hospital.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Elisabeth Mates, MD,PhD, Principal investigator | VA Sierra Nevada Healthcare System | 775-786-7200 | 5273 | Elisabeth.Mates@va.gov |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jul 29, 2025 | Aug 27, 2025 | Prot_SAP_001.pdf |
| ICF | No | No | Yes | Informed Consent Form | Jun 24, 2024 | Oct 8, 2024 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D013832 | Thiamine Deficiency |
| D014899 | Wernicke Encephalopathy |
| D001602 | Beriberi |
| D003693 | Delirium |
| D011115 | Polyneuropathies |
| ID | Term |
|---|---|
| D014804 | Vitamin B Deficiency |
| D001361 | Avitaminosis |
| D003677 | Deficiency Diseases |
| D044342 | Malnutrition |
Not provided
Not provided
Not provided
Not provided
Not provided
No specimen will be retained.
The investigators will determine the low end of normal thiamine levels in veterans with treatment-responsive thiamine deficiency symptoms using a composite score to compare exam findings before and after treatment with thiamine. |
| Baseline compared to follow up visit |
| 20646908 | Background | Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010 Dec;25(4):576-81. doi: 10.1016/j.jcrc.2010.03.003. Epub 2010 Jun 19. |
| 30151974 | Background | Whitfield KC, Bourassa MW, Adamolekun B, Bergeron G, Bettendorff L, Brown KH, Cox L, Fattal-Valevski A, Fischer PR, Frank EL, Hiffler L, Hlaing LM, Jefferds ME, Kapner H, Kounnavong S, Mousavi MPS, Roth DE, Tsaloglou MN, Wieringa F, Combs GF Jr. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Ann N Y Acad Sci. 2018 Oct;1430(1):3-43. doi: 10.1111/nyas.13919. Epub 2018 Aug 27. |
| 11015250 | Background | Lee DC, Chu J, Satz W, Silbergleit R. Low plasma thiamine levels in elder patients admitted through the emergency department. Acad Emerg Med. 2000 Oct;7(10):1156-9. doi: 10.1111/j.1553-2712.2000.tb01268.x. |
| 33305487 | Background | Smith TJ, Johnson CR, Koshy R, Hess SY, Qureshi UA, Mynak ML, Fischer PR. Thiamine deficiency disorders: a clinical perspective. Ann N Y Acad Sci. 2021 Aug;1498(1):9-28. doi: 10.1111/nyas.14536. Epub 2020 Dec 10. |
|
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| Plasma thiamine level | Plasma thiamine level less than 8 nmol/L were considered low | 181 with plasma thiamine biomarker results | Count of Participants | Participants |
|
| Highly sensitive C-reactive protein | Participants with highly sensitive C-reactive protein levels greater than 1.0 mg/dL were considered abnormal / elevated consistent with inflammation. | Only 125 participants had C-reactive protein lab results | Count of Participants | Participants |
|
| Participants |
|
|
| Secondary | Association of Thiamine Deficiency and Inflammation | Determine if there is an association between thiamine deficiency defined by low plasma thiamine levels, and elevated highly sensitive C-reactive protein indicating inflammation. | Participants with results of both plasma thiamine level and C-reactive protein who were thiamine deficient were analyzed to determine if there was an association between thiamine deficiency and increased inflammation. | Posted | Count of Participants | Participants | Baseline |
|
|
|
|
| Secondary | Cut-point Analysis of Thiamine Biomarkers | The investigators will determine the low end of normal thiamine levels in veterans with treatment-responsive thiamine deficiency symptoms using a composite score to compare exam findings before and after treatment with thiamine. | Not Posted | Jun 2026 | Baseline compared to follow up visit | Participants |
| 23 |
| 181 |
| 0 |
| 181 |
| 1 |
| 181 |
Not provided
Not provided
| D009748 |
| Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001928 | Brain Diseases, Metabolic |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D008659 | Metabolic Diseases |
| D019973 | Alcohol-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D003221 | Confusion |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D019965 | Neurocognitive Disorders |
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |